Hiperbilirrubinemia neonatal: revisión de la situación actual

  1. Castaño Picó, María José
  2. Sánchez Maciá, Miriam
Revista:
RECIEN: Revista Científica de Enfermería (España)

ISSN: 1989-6409

Año de publicación: 2011

Número: 2

Tipo: Artículo

DOI: 10.14198/RECIEN.2011.02.06 DIALNET GOOGLE SCHOLAR lock_openDialnet editor

Otras publicaciones en: RECIEN: Revista Científica de Enfermería (España)

Objetivos de desarrollo sostenible

Resumen

TITLE: NEONATAL HYPERBILIRUBINEMIA: REVIEW OF THE CURRENT SITUATION.OBJECTIVE: to determine the incidence of neonatal hyperbilirubinemia. DESIGN: Bibliometric transverse descriptive study realized by literature searching in the Virtual Health Library, Web of Science and Medline with the keywords "hiperbilirrubinemia neonatal" / "neonatal hyperbilirubinemia" "ictericia neonatal"/"neonatal jaundice" "epidemiología "/"epidemiology" "incidencia"/" incidence" in the period understood between 0150152007 up to 3l 3151252010. We excluded articles on neonatal hyperbilirubinemia prolonged, extreme neonatal hyperbilirubinemia and exchange transfusion. There were no limits in the language. RESULTS: In the United States, 15.6% of newborns develop neonatal jaundice, and Nigeria is 6'7%. In Europe, neonatal hyperbilirubinemia varies from 59% found in Sweden to 28.5% in Rome, 11% in Portugal, or 6% in Greece. The incidence of neonatal hyperbilirubinemia in Pakistan is 39'7 / 1.000, while in Denmark is 1.4 per 100.000 births at term or near preterm. The incidence in Spain stands at 1'93 / 10.000 in 2007 and 1'69 / 10.000 in 2009. The incidence of severe hyperbilirubinemia in the United Kingdom is 7'1 / 100.000. CONCLUSIONS: A high variability due to multi5causal origin of the disease. Spain has a low incidence of neonatal hyperbilirubinemia, although the lowest incidence was found within Denmark.

Referencias bibliográficas

  • Fernández Rodríguez M, Martín Muñoz P. La valoración clínica de la ictericia no es buen método para el cribado de hiperbilirrubinemianeonatal. EvidPediar. 2008; 4: 77.
  • Cohen RS, Ronald JW, Stevenson DK. Understanding Neonatal Jaundice: A Perspective on Causation. PediatrNeonatol. 2010; 51(3):143−48.
  • Wu J, Su W, Jin Y, Shi Y, Li C, Zhong W et al. Targeted suppression of heme oxygenase-1 by small interference RNAs inhibits the production of bilirubin in neonatal rat with hyperbilirubinemia. BMC Mol Biol. 2009; 10: 77.
  • Puebla Molina SF, Aparicio Sánchez JL. En el tratamiento de la ictericia neonatal, el uso de cortinas blancas reflectantes de bajo coste alrededor de la zona de fototerapia incrementa significativamente la eficacia de ésta. EvidPediatr. 2007; 3:18.
  • Maisels MJ, McDonagh AF. Phototherapy for Neonatal Jaundice. N Engl J Med. 2008; 358:920-8.
  • Watchko JF, Lin ZL. Exploring the genetic architecture of neonatal hyperbilirubinemia.Semin Fetal Neonatal Med. 2010; 15 (3): 169-75.
  • Checa DA. Manual DAE de enfermería; EIR; Oposiciones. 1ª ed. Madrid: Difusión Avances de Enfermería; 2009.
  • Rennie J, Burman-Roy S, Murphy S. Neonatal jaundice: summary of NICE guidance. BMJ. 2010; 340:c2409.
  • Huang MS, Lin MC, Chen HH,Chien KL, Chen CH. Risk Factor Analysis for Late-onset Neonatal Hyperbilirubinemia in Taiwanese Infants. PediatrNeonatol. 2009; 50(6):261−65.
  • Burke BL, Robbins JM, Mac Bird T, Hobbs CA, Nesmith C, Tilford JM. Trends in Hospitalizations for Neonatal Jaundice and Kernicterus in the United States, 1988-2005. Pediatrics. 2009; 123(2):524-32.
  • Picone S,Paolillo P. Neonatal outcomes in a population of late-preterm infants. J Matern Fetal Neonatal Med. 2010; 23(S3):116-20.
  • Manning D, Todd P, Maxwell M, Plait MJ. Prospective surveillance study of severe hyperbilirubinaemia in the newborn in the UK and Ireland.Arch Dis Child Fetal Neonatal Ed.2007; 92(5):342-46.
  • Altman M, Vanpée M, Cnattingius S, Norman M. Neonatal morbidity in moderately preterm infants: a Swedish national population-based study.J Pediatr. 2011; 158(2):239-44.
  • Tikmani SS, Warraich HJ, Abbasi F, Rizvi A, Darmstadt GL, Zaidi AKM. Incidence of neonatal hyperbilirubinemia: a population-based prospective study in Pakistan.Trop Med Int Health.2010; 15(5): 502-07.
  • Olusanya BO, Akande AA, Emokpae A, Olowe SA. Infants with severe neonatal jaundice in Lagos, Nigeria: incidence, correlates and hearing screening outcomes. Trop Med Int Health. 2009; 14(3): 301-10.
  • Sankaran K. Hyperbilirubinemia in newborns with gestation ≥35 weeks. Zhongguo Dang Dai ErKeZaZhi. 2010; 12(10):761-6.
  • Gonçalves A, Costa S, Lopes A, Rocha G, Guedes MB, Centeno MJ et al. Prospective validation of a novel strategy for assessing risk of significant RECIEN Nº 2 Mayo 2011 Pág. - 10 Recien Revista Científica de Enfermería hyperbilirubinemia. Pediatrics. 2011; 127(1):e126-31.
  • Varvarigou A, Fouzas S, Skylogianni E, Mantagou L, Bougioukou D, Mantagos S. Transcutaneous bilirubin nomogram for prediction of significant neonatal hyperbilirubinemia. Pediatrics. 2009; 124; 1052-59.
  • Consulta interactiva SNS [Internet]. Madrid: Ministerio de Sanidad, Política Social e Igualdad; [acceso 8 febrero 2011]. Instituto de Información Sanitaria. Registro de altas – CMBD. Disponible en: http://pestadistico.msc.es
  • Núñez-Batalla F, Carro-Fernández P, Antuña-León ME, González-Trelles T. Incidencia de hipoacusia secundaria a hiperbilirrubinemia en un programa de cribado auditivo neonatal universal basado en otoemisiones acústicas y potenciales evocados auditivos.Acta Otorrinolaringol Esp. 2008;59(3):108-13.
  • Briese V, Voigt M, Hermanussen M, Wittwer-Backofen U.Morbid obesity: Pregnancy risks, birth risks and status of the newborn. Homo. 2010; 61(1):64-72.
  • Trikalinos TA, Chung M, Lau J, Ip S. Systematic review of screening for bilirubin encephalopathy in neonates. Pediatrics. 2009; 124: 1162-71.
  • Watchko JF. Hyperbilirubinemia in African American neonates: clinical issues and current challenges. Semin Fetal Neonatal Med.2010; 15(3):176-82.
Fuente de los datos: Dialnet